Details of the Drug | DrugMAP

General Information of Drug (ID: DMN9VKM)

Drug Name

Dasiprotimut-T

Indication

Disease Entry	ICD 11	Status	REF
Lymphoma	2A80-2A86	Phase 3	[1]
------------------------------------------------------------------------------------

ATC Code

L03AX19: Dasiprotimut-T

L03AX: Other immunostimulants

L03A: IMMUNOSTIMULANTS

L03: IMMUNOSTIMULANTS

L: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS

Cross-matching ID

DrugBank ID: DB17287
TTD ID: D00PTZ

References

1	ClinicalTrials.gov (NCT00091676) Study of the BiovaxId Tumor Derived Idiotype Vaccine in Patients With Follicular Lymphoma. U.S. National Institutes of Health.